GenSight Biologics S.A.

SIGHT.PA · PAR
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-€7-€8-€6-€14
Dep. & Amort.€0€0€1€2
Deferred Tax€0€0€0€0
Stock-Based Comp.€0€0€0€0
Change in WC€2€1€0€6
Other Non-Cash€2€1-€3-€3
Operating Cash Flow-€2-€6-€7-€8
Investing Activities
PP&E Inv.€0€0-€0-€0
Net Acquisitions€0€0€0€0
Inv. Purchases-€0€0€0€0
Inv. Sales/Matur.€0€0€0€0
Other Inv. Act.€0€0€0€0
Investing Cash Flow-€0€0€0€0
Financing Activities
Debt Repay.-€0-€2-€0€0
Stock Issued€1€0€13€0
Stock Repurch.€0-€11-€0-€0
Dividends Paid€0€0€0€0
Other Fin. Act.-€0€15€13€10
Financing Cash Flow€1€2€12€9
Forex Effect€0-€0€0€0
Net Chg. in Cash-€2-€4€5€1
Supplemental Information
Beg. Cash€2€7€2€1
End Cash€0€2€7€1
Free Cash Flow-€2-€6-€7-€8
GenSight Biologics S.A. (SIGHT.PA) Financial Statements & Key Stats | AlphaPilot